Published in
Elsevier, European Journal of Cancer - Supplement, 2(7), p. 357
DOI: 10.1016/s1359-6349(09)71210-8
Links
Tools
6115 VEGF gene polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts)
Journal article published in 2009 by
F. Loupakis,
A. Ruzzo,
L. Salvatore 
,
E. Canestrari,
C. Cremolini,
D. Santini,
K. Bencardino,
M. Manzoni,
A. Falcone,
F. Graziano
,
E. Canestrari,
C. Cremolini,
D. Santini,
K. Bencardino,
M. Manzoni,
A. Falcone,
F. Graziano
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 